Health
Personalized genetic testing helps reduce adverse events following balloon angioplasty – News-Medical.Net
An international, first-of-its-kind cardiology trial used personalized genetic testing to reduce by 34 per cent the number of serious adverse events following balloon angioplasty, a treatment for the most common form of heart disease.
An international, first-of-its-kind cardiology trial used personalized genetic testing to reduce by 34 percent the number of serious adverse events following balloon angioplasty, a treatment for the most common form of heart disease.
For patients undergoing percutaneous coronary intervention (PCI)-; a non-surgical procedure where physicians inflate a balloon and place a metal stent in narrowed heart arteries to improve blood flow to the heart-;the choice of antiplatelet therapy can be critical …
-
General20 hours ago‘Potential’ hacker contacts Qantas over data breach
-
Noosa News6 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business11 hours agoFord CEO makes stunning prediction about artificial intelligence
-
General21 hours agoStrictly embargoed! The gaming of the press release